ANSTO leverages great science to deliver big outcomes. We partner with scientists and engineers and apply new technologies to provide real-world benefits. Our work improves human health, saves lives, builds our industries and protects the environment. ANSTO is a leading player in the development and translation of radiopharmaceuticals to improve the detection and diagnosis of disease. ANSTO has the expertise and capabilities to supply radioisotopes and undertake radiochemistry, radiation biology and preclinical imaging studies to develop and evaluate radiopharmaceuticals. This includes the use of new radioisotopes from the OPAL multipurpose reactor.